AI assistant
CASTLE BIOSCIENCES INC — Director's Dealing 2021
Jan 11, 2021
32601_dirs_2021-01-11_19e168c6-bd45-4954-86fd-5accab448ae8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: CASTLE BIOSCIENCES INC (CSTL)
CIK: 0001447362
Period of Report: 2020-12-31
Reporting Person: BRADBURY DANIEL (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-08 | Common Stock | G | 157804 | — | Disposed | 573387 | Indirect |
| 2020-12-08 | Common Stock | G | 157781 | — | Disposed | 415606 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 157804 | Indirect |
| Common Stock | 157781 | Indirect |
Footnotes
F1: On December 8, 2020, the reporting person transferred 157,804 shares of Castle Biosciences, Inc. common stock to the Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.
F2: Held by BioBrit, LLC (the "LLC"), of which the Reporting Person is the managing member and has voting and investment power over the shares.
F3: On December 8, 2020, the reporting person transferred 157,781 shares of Castle Biosciences, Inc. common stock to the Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.